CU6 1.54% $6.60 clarity pharmaceuticals ltd

Don't miss the term platform...The receipt of the $10 million...

  1. 819 Posts.
    lightbulb Created with Sketch. 41
    Don't miss the term platform...

    The receipt of the $10 million will provide additional funding to further the development of Clarity’s TCT platform of products for various cancer indications.

    TCT - Targeted Copper Theranostics

    The Company is a leader in innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.